TITLE

Pantoprazole is more effective than ranitidine in reducing the duration of esophageal acid contact

AUTHOR(S)
Pratha, Vijaya S; Soffer, Elaine; Hogan, Daniel L; Wang, Wenjin
PUB. DATE
September 2003
SOURCE
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS31
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Pantoprazole Is More Effective Than Ranitidine in Reducing the Duration of Esophageal Acid Contact," by Vijaya S. Pratha, Elaine Soffer, Daniel L. Hogan and Wenjin Wang is presented.
ACCESSION #
66954489

 

Related Articles

  • New Meaning for the Term 'Hacking'. Phillips, Barbara A. // Internal Medicine Alert;5/15/2013, Vol. 35 Issue 9, p65 

    This meta-analysis did not convincingly demonstrate a positive effect of gastric acid-suppressing treatment in patients with chronic cough.

  • Omeprazole was effective in the short term for uninvestigated dyspepsia. Rabeneck, L.; Souchek, J.; Wristers, k.; Talley, Nicholas J. // ACP Journal Club;May/Jun2003, Vol. 138 Issue 3, p70 

    Summarizes a study that determined whether a proton-pump inhibitor is effective in the treatment of patients with uninvestigated dyspepsia. Characterization of the patients; Main outcome measures; Results of the study.

  • Subacute Cutaneous Lupus Erythematosus Induced or Exacerbated by Proton Pump Inhibitors. Dam, Claus; Bygum, Anette // Acta Dermato-Venereologica;2008, Vol. 88 Issue 1, p87 

    A letter to the editor is presented concerning the treatment of subacute cutaneous lupus erythematosus using proton pump inhibitors.

  • PPIs and clopidogrel.  // Critical Care Alert;May2009 Pharmacology Watch, p2 

    The article focuses on the efficiency of proton pump inhibitors (PPIs) in reducing the effect of clopidogrel on platelet aggregate.

  • Pantoprazole intravenous. My-Trang Le; Cano, Steven // Drug Utilization Review;Nov2001, Vol. 17 Issue 11, p1 

    Presents information on pantoprazole, an intravenous form of the benzimidazole proton pump inhibitor class drug. Pharmacokinetics; Pharmacodynamics; Dosage and administration.

  • Biological Plausibility Between Proton Pump Inhibitory Therapy and Hip Fracture: Hypermocysteinemia Can Be the Link. Roblin, Xavier; Phelip, Jean Marc // American Journal of Gastroenterology;Apr2009, Vol. 104 Issue 4, p1052 

    A letter to the editor is presented in response to the article regarding the biological validity of proton pump inhibitory therapy (PPI) and hip fracture in the previous issue.

  • It Is Difficult to Discontinue PPI Treatment in Patients With GERD. Bjornsson, Einar // American Journal of Gastroenterology;Feb2011, Vol. 106 Issue 2, p367 

    A letter to the editor is presented in response to an article regarding the development of dyspepsia in healthy volunteers after stopping proton-pump inhibitors (PPI) therapy.

  • Omeprazole.  // Reactions Weekly;8/21/2010, Issue 1315, p37 

    The article describes the case of a 52-year-old woman who took omeprazile for acid reflux and developed burning mouth syndrome-like symptoms.

  • Omeprazole/pantoprazole.  // Reactions Weekly;8/21/2010, Issue 1315, p37 

    The article describes the case of a 60-year-old man who had neutropenia initially while taking omeprazole and later during treatment with pantoprazole.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics